Old Web
English
Sign In
Acemap
>
Paper
>
Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
2021
Gilad Itchaki
Keywords:
Immunology
Messenger RNA
in patient
Immune system
Coronavirus disease 2019
Chronic lymphocytic leukemia
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]